Business Organigram reports 22% revenue gain for 2nd straight quarter The company will be EBITDA-positive by Q3, CEO says Nick LabaJanuary 11, 2022
Business Organigram gains Quebec foothold with $36M Laurentian acquisition The deal also adds premium flower and hash to its portfolio Nick LabaDecember 22, 2021
Business Organigram shares rise on 22% revenue boost The firm's new CEO looks to be off to a strong start Nick LabaNovember 23, 2021
News Organigram drops CEO shortly after big tobacco investment Since receiving $221M from British American Tobacco, the Canadian cannabis firm has reported declining revenue Jared GnamMay 3, 2021
Industry update Can you buy brand loyalty? Canopy thinks so While Canopy says its building authentic brands, weed industry insiders criticize the pot giant for attempting to buy brand loyalty instead of earning it Jared GnamApril 1, 2021
Industry update Organigram shares surge on big tobacco deal British American Tobacco to invest $221M in the Canadian producer to develop new innovative weed and CBD products Jared GnamMarch 11, 2021
Industry update Organigram shares sink as sales shrink High-cost cultivation without premium brands is a losing combo for the New Brunswick producer, analyst says Jared GnamJanuary 12, 2021
The weed wire Village Farms buys 100% ownership of Pure Sunfarms for $80M Emerald Health Therapeutics sells its 41.3% stake in the previous joint venture Michelle GamageSeptember 8, 2020
Analysis Is Village Farms poised to be an industry leader? Raymond James analysts forecast the vegetable grower will take full ownership of its Pure Sunfarms joint venture and a 20% share of Canada's weed... Jared GnamAugust 27, 2020
The weed wire Aphria joins Israeli medical cannabis rush with new supply deal The Canadian producer signed a deal with Israel's Canndoc that could extend up to seven years Jared GnamAugust 5, 2020